Disease | metabolic syndrome x |
Comorbidity | C0010068|coronary disease |
Sentences | 4 |
PubMedID- 21196002 | [prevalence of metabolic syndrome in patients with stable coronary disease: therapeutic objectives and utilization of cardiovascular drugs]. |
PubMedID- 25971444 | North america, europe, and australiathe effect of rimonabant on regression of coronary disease in patients with the metabolic syndrome and cad2008335/341cad,obesity87.6/86.3−4.7/-3.6rim 20 mg vs placebo on bases of statins therapy18rim can reduce progression of coronary plaque, and increase hdl-c levels, decrease triglyceride levels.hiro t20; japan-acsrct: prospective, randomized, open-label, parallel group, multicenter. |
PubMedID- 20674994 | Likelihood of obstructive coronary disease in metabolic syndrome patients with abnormal stress echocardiography. |
PubMedID- 20209376 | Highly sensitive c-reactive protein and male gender are independently related to the severity of coronary disease in patients with metabolic syndrome and an acute coronary event. |
Page: 1